Catalog # PM0801

PD-L1 (Extracellular region) M080 Antibody

Mouse Monoclonal

Application Dilution
ELISA (Cap)1:200
ICC1:200
IP1:200
WB1:500

Size 100 μl

Species Reactivity Hu, Rt, Ms

MW 45-55 kDa

Isotype IgG1

DATASHEET  




$325

Programmed cell death 1 ligand 1 (PD-L1, B7-H1, CD274) is a member of the B7 family of cell surface ligands that regulate T cell activation and immune responses. The B7 family members have conserved regions that include extracellular IgV and IgC domains, and a short cytoplasmic region. Research studies demonstrate that PD-L1 is expressed in several tumor types, including melanoma, ovary, colon, lung, breast, and renal cell carcinomas. PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, which promotes tumor survival. The blockage of the PD1/PD-L1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy. Several therapies that target PD1/PD-L1 pathways are currently in use or in clinical trials.

References

Dong, H. et al. (1999) Nat Med. 5:1365.
Pardoll, D.M. (2012) Nat Rev Cancer. 12:252.

Western blot of human recombinant PD-L1 extracellular region (40 kDa; lane 1), mouse J774A.1 macrophage control (lane 2) and LPS treated (lane 3), and mouse RAW264.7 macrophage control (lane 4) and LPS treated (lane 5). The blot was probed with mouse monoclonal anti-PD-L1 (PM0801) at 1:250.

Immunocytochemical labeling of PD-L1 in aldehyde fixed human MDA-MB-231 carcinoma cells untreated (A) or treated with 100 ng/ml IFNγ for 48 hrs (B). The cells were labeled with mouse monoclonal anti-PD-L1 (PM0801). The antibody was detected using goat anti-mouse DyLight® 594.



Representative Standard Curve using mouse monoclonal anti-PD-L1 (PM0801) for ELISA capture of human recombinant PD-L1 extracellular region with a His-tag. Captured protein was detected by suitable anti-His-tag antibody followed by appropriate secondary antibody HRP conjugate.

Clone (M080) was generated from a recombinant protein that included the extracellular region of human PD-L1 protein.

*For more information, see UniProt Accession Q9NZQ7
Mouse monoclonal antibody purified with protein G chromatography is supplied in 100 µl phosphate-buffered saline, 50% glycerol, 1 mg/ml BSA, and 0.05% sodium azide. Store at –20°C. Stable for 1 year.

The products are are safely shipped at ambient temperature for both domestic and international shipments. Each product is guaranteed to match the specifications as indicated on the corresponding technical data sheet. Please store at -20C upon arrival for long term storage.

Clone M080 mouse monoclonal antibody detects a 45-55 kDa* protein on SDS-PAGE "Native" or denatured immunoblots of human MDA-MB-231 carcinomas, as well as mouse J774A.1 or RAW264.7 macrophage treated with LPS. The antibody works for western blot, immunoprecipitation, immunocytochemistry, and ELISA capture.

*All molecular weights (MW) are confirmed by comparison to Bio-Rad Rainbow Markers and to western blot mobilities of known proteins with similar MW.

This kit contains:

KIT SUMMARY